Pharmacophore-based drug design of novel potential tau ligands for Alzheimer's disease treatment (2014)
- Autores:
- Autor USP: SILVA, CARLOS HENRIQUE TOMICH DE PAULA DA - FCFRP
- Unidade: FCFRP
- DOI: 10.2174/18779468113036660020
- Assuntos: DOENÇA DE ALZHEIMER (TRATAMENTO); PROTEÍNAS
- Idioma: Inglês
- Imprenta:
- Fonte:
- Título do periódico: Current Physical Chemistry
- ISSN: 1877-9476
- Volume/Número/Paginação/Ano: v. 4, n. 1, p. 35-44, 2014
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
PEDERSOLI-MANTOANI, Susimaire et al. Pharmacophore-based drug design of novel potential tau ligands for Alzheimer's disease treatment. Current Physical Chemistry, v. 4, n. 1, p. 35-44, 2014Tradução . . Disponível em: https://doi.org/10.2174/18779468113036660020. Acesso em: 18 set. 2024. -
APA
Pedersoli-Mantoani, S., Silva, V. B. da, Taft, C. A., & Silva, C. H. T. de P. da. (2014). Pharmacophore-based drug design of novel potential tau ligands for Alzheimer's disease treatment. Current Physical Chemistry, 4( 1), 35-44. doi:10.2174/18779468113036660020 -
NLM
Pedersoli-Mantoani S, Silva VB da, Taft CA, Silva CHT de P da. Pharmacophore-based drug design of novel potential tau ligands for Alzheimer's disease treatment [Internet]. Current Physical Chemistry. 2014 ; 4( 1): 35-44.[citado 2024 set. 18 ] Available from: https://doi.org/10.2174/18779468113036660020 -
Vancouver
Pedersoli-Mantoani S, Silva VB da, Taft CA, Silva CHT de P da. Pharmacophore-based drug design of novel potential tau ligands for Alzheimer's disease treatment [Internet]. Current Physical Chemistry. 2014 ; 4( 1): 35-44.[citado 2024 set. 18 ] Available from: https://doi.org/10.2174/18779468113036660020 - Sequence and transcriptional study of HNRPK pseudogenes, and expression and molecular modeling analysis of hnRNP K isoforms
- Use of virtual screening, flexible docking, and molecular interaction fields to design novel HMG-CoA reductase inhibitors for the treatment of hypercholesterolemia
- Molecular modeling approaches of selective adenosine receptor type 2A agonists as potential anti-inflammatory drugs
- Identification of novel chemical entities for Adenosine receptor type 2A using molecular modeling approaches
- Química computacional no planejamento de candidatos a quimioterápicos
- Parkinson’s disease: a review from pathophysiology to treatment
- Novel chalcones derivatives with potential antineoplastic activity investigated by docking and molecular dynamics simulations
- Computer-aided drug design and ADMET predictions for identification and evaluation of novel potential farnesyltransferase
- General aspects of lead finding and optimization in drug discovery
- Molecular dynamics, density functional theory, pharmacophore modeling, molecular interaction fields and ADME/tox investigation of novel bioactive compounds interacting with CDK2 surfaces
Informações sobre o DOI: 10.2174/18779468113036660020 (Fonte: oaDOI API)
Como citar
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
